Analysis of the longest follow-up data yet suggests major outcomes are similar after trans-catheter (TAVR) or surgical aortic valve replacement (SAVR) in low-risk patients.

But secondary outcomes differ, with atrial fibrillation more common in surgical patients, while rates of post-procedural pacemaker implantation and paravalvular leaks are higher with TAVR.